Stanford Synchrotron Radiation Lightsource (SSRL)

SLAC and Stanford partner with Argonne National Laboratory and others toward a quantum-interconnected world.

X-rays unveil new molecular structure details that will help researchers design novel drug therapies to address antibiotic resistant bacteria.

His visit highlighted the breadth of our world-class research and the people and collaborations that make it possible. A key theme of the day: how SLAC and the National Labs are advancing AI to accelerate discovery.

Shweta Saraf and her team work to ensure the LCLS beamline runs without interruption. 

The upgrades to SSRL’s resonant soft X-ray scattering beam line could reveal the hidden physics in high-temperature superconductors.

SLAC researchers drew on advanced computation and X-ray methods to track down a water-splitting copper catalyst.

He met with SLAC staff and toured the lab’s cutting-edge facilities, diving into world-leading research in X-ray and ultrafast science, artificial intelligence, astrophysics and more.

Oxidizing chemicals break this cellular power plant into useless bits, leading to  Parkinson’s disease, ALS, heart disease, diabetes, cancer and more. A small molecule could block the process.

Developed at SSRL, the method could help make those electrochemical conversions more robust and efficient.

Advanced imaging technique reveals catalyst degradation processes, addressing a key barrier to converting carbon dioxide into liquid fuel.

The new findings highlight the need for ongoing monitoring of H5N1’s evolution in nature. 

Following a boom in catalysis users at SSRL, Beam Line 10-2 has been transformed and outfitted with new technologies.